Shingo Matsuo
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Inhibition of ubiquitin-activating enzyme protects against organ injury after intestinal ischemia-reperfusion.
Journal: American journal of physiology. Gastrointestinal and liver physiology
Published: May 18, 2018
PYR-41, A Ubiquitin-Activating Enzyme E1 Inhibitor, Attenuates Lung Injury in Sepsis.
Journal: Shock (Augusta, Ga.)
Published: June 30, 2017
Milk fat globule epidermal growth factor-factor 8-derived peptide attenuates organ injury and improves survival in sepsis.
Journal: Critical care (London, England)
Published: July 02, 2015
Differential alterations of tissue T-cell subsets after sepsis.
Journal: Immunology letters
Published: April 08, 2015
MFG-E8 inhibits neutrophil migration through αvβ₃-integrin-dependent MAP kinase activation.
Journal: International journal of molecular medicine
Published: February 18, 2015
Receptor-interacting protein kinase 3 deficiency inhibits immune cell infiltration and attenuates organ injury in sepsis.
Journal: Critical care (London, England)
Published: April 15, 2014
Upregulation of GRAIL is associated with impaired CD4 T cell proliferation in sepsis.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: January 31, 2014
FK866, a visfatin inhibitor, protects against acute lung injury after intestinal ischemia-reperfusion in mice via NF-κB pathway.
Journal: Annals of surgery
Published: October 31, 2013
Fatty acid synthase inhibitor C75 ameliorates experimental colitis.
Journal: Molecular medicine (Cambridge, Mass.)
Published: September 27, 2013
Cyclic arginine-glycine-aspartate attenuates acute lung injury in mice after intestinal ischemia/reperfusion.
Journal: Critical care (London, England)
Published: September 18, 2012
Showing 1-10 of 10
Last Updated: 09/26/2026